134 related articles for article (PubMed ID: 38846351)
1. Molecular characterization of SARS-CoV-2 nucleocapsid protein.
Huang Y; Chen J; Chen S; Huang C; Li B; Li J; Jin Z; Zhang Q; Pan P; Du W; Liu L; Liu Z
Front Cell Infect Microbiol; 2024; 14():1415885. PubMed ID: 38846351
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2, the pandemic coronavirus: Molecular and structural insights.
Kadam SB; Sukhramani GS; Bishnoi P; Pable AA; Barvkar VT
J Basic Microbiol; 2021 Mar; 61(3):180-202. PubMed ID: 33460172
[TBL] [Abstract][Full Text] [Related]
3. Evolution of SARS-CoV-2 Envelope, Membrane, Nucleocapsid, and Spike Structural Proteins from the Beginning of the Pandemic to September 2020: A Global and Regional Approach by Epidemiological Week.
Troyano-Hernáez P; Reinosa R; Holguín Á
Viruses; 2021 Feb; 13(2):. PubMed ID: 33557213
[TBL] [Abstract][Full Text] [Related]
4. Modulation of biophysical properties of nucleocapsid protein in the mutant spectrum of SARS-CoV-2.
Nguyen A; Zhao H; Myagmarsuren D; Srinivasan S; Wu D; Chen J; Piszczek G; Schuck P
Elife; 2024 Jun; 13():. PubMed ID: 38941236
[TBL] [Abstract][Full Text] [Related]
5. Identification of SARS-CoV-2 Nucleocapsid and Spike T-Cell Epitopes for Assessing T-Cell Immunity.
Lee E; Sandgren K; Duette G; Stylianou VV; Khanna R; Eden JS; Blyth E; Gottlieb D; Cunningham AL; Palmer S
J Virol; 2021 Feb; 95(6):. PubMed ID: 33443088
[TBL] [Abstract][Full Text] [Related]
6. MERS-CoV and SARS-CoV-2 replication can be inhibited by targeting the interaction between the viral spike protein and the nucleocapsid protein.
Park BK; Kim J; Park S; Kim D; Kim M; Baek K; Bae JY; Park MS; Kim WK; Lee Y; Kwon HJ
Theranostics; 2021; 11(8):3853-3867. PubMed ID: 33664866
[No Abstract] [Full Text] [Related]
7. Monoclonal Antibodies to S and N SARS-CoV-2 Proteins as Probes to Assess Structural and Antigenic Properties of Coronaviruses.
Kumar R; Christensen ND; Kaddis Maldonado RJ; Bewley MC; Ostman A; Sudol M; Chen EC; Buchkovich NW; Gontu A; Surendran Nair M; Nissly RH; Minns AM; Kapur V; Rossi R; Kuchipudi SV; Lindner SE; Parent LJ; Flanagan JM; Buchkovich NJ
Viruses; 2021 Sep; 13(10):. PubMed ID: 34696329
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 (COVID-19) structural and evolutionary dynamicome: Insights into functional evolution and human genomics.
Gupta R; Charron J; Stenger CL; Painter J; Steward H; Cook TW; Faber W; Frisch A; Lind E; Bauss J; Li X; Sirpilla O; Soehnlen X; Underwood A; Hinds D; Morris M; Lamb N; Carcillo JA; Bupp C; Uhal BD; Rajasekaran S; Prokop JW
J Biol Chem; 2020 Aug; 295(33):11742-11753. PubMed ID: 32587094
[TBL] [Abstract][Full Text] [Related]
9. Molecular insight into the genomic variation of SARS-CoV-2 strains from current outbreak.
Das A; Khurshid S; Ferdausi A; Nipu ES; Das A; Ahmed FF
Comput Biol Chem; 2021 Aug; 93():107533. PubMed ID: 34166886
[TBL] [Abstract][Full Text] [Related]
10. Single Immunization with Recombinant ACAM2000 Vaccinia Viruses Expressing the Spike and the Nucleocapsid Proteins Protects Hamsters against SARS-CoV-2-Caused Clinical Disease.
Deschambault Y; Lynch J; Warner B; Tierney K; Huynh D; Vendramelli R; Tailor N; Frost K; Sajesh B; LeBlanc K; Layne C; Lin L; Tamming L; Beniac D; Booth S; Carpenter M; Safronetz D; Li X; Kobasa D; Cao J
J Virol; 2022 May; 96(9):e0038922. PubMed ID: 35412347
[TBL] [Abstract][Full Text] [Related]
11. Properties of Coronavirus and SARS-CoV-2.
Malik YA
Malays J Pathol; 2020 Apr; 42(1):3-11. PubMed ID: 32342926
[TBL] [Abstract][Full Text] [Related]
12. A computational approach to design potential siRNA molecules as a prospective tool for silencing nucleocapsid phosphoprotein and surface glycoprotein gene of SARS-CoV-2.
Chowdhury UF; Sharif Shohan MU; Hoque KI; Beg MA; Sharif Siam MK; Moni MA
Genomics; 2021 Jan; 113(1 Pt 1):331-343. PubMed ID: 33321203
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 structural coverage map reveals viral protein assembly, mimicry, and hijacking mechanisms.
O'Donoghue SI; Schafferhans A; Sikta N; Stolte C; Kaur S; Ho BK; Anderson S; Procter JB; Dallago C; Bordin N; Adcock M; Rost B
Mol Syst Biol; 2021 Sep; 17(9):e10079. PubMed ID: 34519429
[TBL] [Abstract][Full Text] [Related]
14. Evolutionary dynamics of SARS-CoV-2 nucleocapsid protein and its consequences.
Rahman MS; Islam MR; Alam ASMRU; Islam I; Hoque MN; Akter S; Rahaman MM; Sultana M; Hossain MA
J Med Virol; 2021 Apr; 93(4):2177-2195. PubMed ID: 33095454
[TBL] [Abstract][Full Text] [Related]
15. Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies.
Ahmed SF; Quadeer AA; McKay MR
Viruses; 2020 Feb; 12(3):. PubMed ID: 32106567
[TBL] [Abstract][Full Text] [Related]
16. The Proteins of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS CoV-2 or n-COV19), the Cause of COVID-19.
Yoshimoto FK
Protein J; 2020 Jun; 39(3):198-216. PubMed ID: 32447571
[TBL] [Abstract][Full Text] [Related]
17. From SARS and MERS CoVs to SARS-CoV-2: Moving toward more biased codon usage in viral structural and nonstructural genes.
Kandeel M; Ibrahim A; Fayez M; Al-Nazawi M
J Med Virol; 2020 Jun; 92(6):660-666. PubMed ID: 32159237
[TBL] [Abstract][Full Text] [Related]
18. Identification of Unique Peptides for SARS-CoV-2 Diagnostics and Vaccine Development by an
Kesarwani V; Gupta R; Vetukuri RR; Kushwaha SK; Gandhi S
Front Immunol; 2021; 12():725240. PubMed ID: 34630400
[TBL] [Abstract][Full Text] [Related]
19. Evidence for mutations in SARS-CoV-2 Italian isolates potentially affecting virus transmission.
Benvenuto D; Demir AB; Giovanetti M; Bianchi M; Angeletti S; Pascarella S; Cauda R; Ciccozzi M; Cassone A
J Med Virol; 2020 Oct; 92(10):2232-2237. PubMed ID: 32492183
[TBL] [Abstract][Full Text] [Related]
20. Epitope-based peptide vaccines predicted against novel coronavirus disease caused by SARS-CoV-2.
Lin L; Ting S; Yufei H; Wendong L; Yubo F; Jing Z
Virus Res; 2020 Oct; 288():198082. PubMed ID: 32621841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
